These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8615082)

  • 21. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms.
    Sergeant N; Wattez A; Delacourte A
    J Neurochem; 1999 Mar; 72(3):1243-9. PubMed ID: 10037497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration.
    Bergeron C; Pollanen MS; Weyer L; Lang AE
    J Neuropathol Exp Neurol; 1997 Jun; 56(6):726-34. PubMed ID: 9184663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer's disease.
    Li F; Iseki E; Odawara T; Kosaka K; Yagishita S; Amano N
    J Neurol Sci; 1998 Jul; 159(1):73-81. PubMed ID: 9700707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuropathology of corticobasal degeneration].
    Wakabayashi K; Takahashi H
    No To Shinkei; 1996 Jun; 48(6):521-32. PubMed ID: 8703555
    [No Abstract]   [Full Text] [Related]  

  • 26. Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy.
    Borghi R; Giliberto L; Assini A; Delacourte A; Perry G; Smith MA; Strocchi P; Zaccheo D; Tabaton M
    Neurology; 2002 Feb; 58(4):589-92. PubMed ID: 11865137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphological overlap between corticobasal degeneration and Pick's disease: a clinicopathological report.
    Jendroska K; Rossor MN; Mathias CJ; Daniel SE
    Mov Disord; 1995 Jan; 10(1):111-4. PubMed ID: 7885345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy.
    Komori T; Arai N; Oda M; Nakayama H; Mori H; Yagishita S; Takahashi T; Amano N; Murayama S; Murakami S; Shibata N; Kobayashi M; Sasaki S; Iwata M
    Acta Neuropathol; 1998 Oct; 96(4):401-8. PubMed ID: 9797005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive supranuclear palsy with fronto-temporal atrophy and various tau-positive abnormal structures.
    Li F; Iseki E; Kosaka K; Nishimura T; Akiyama H; Kato M
    Clin Neuropathol; 1996; 15(6):319-23. PubMed ID: 8937777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of progressive supranuclear palsy with widespread senile plaques.
    Sasaki S; Maruyama S; Toyoda C
    J Neurol; 1991 Sep; 238(6):345-8. PubMed ID: 1940988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy.
    Arai T; Ikeda K; Akiyama H; Shikamoto Y; Tsuchiya K; Yagishita S; Beach T; Rogers J; Schwab C; McGeer PL
    Acta Neuropathol; 2001 Feb; 101(2):167-73. PubMed ID: 11271372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive supranuclear palsy on Guam.
    Yamazaki M; Makifuchi T; Chen KM; Mori O; Katayama Y; Takahashi H; Oyanagi K
    Acta Neuropathol; 2001 Nov; 102(5):510-4. PubMed ID: 11699567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration.
    Yoshida M
    Neuropathology; 2014 Dec; 34(6):555-70. PubMed ID: 25124031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presenile dementia with progressive supranuclear palsy tangles and Pick bodies: an unusual degenerative disorder involving the cerebral cortex, cerebral nuclei, and brain stem nuclei.
    Arima K; Murayama S; Oyanagi S; Akashi T; Inose T
    Acta Neuropathol; 1992; 84(2):128-34. PubMed ID: 1381857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticobasal degeneration: an autopsy case clinically diagnosed as progressive supranuclear palsy.
    Shiozawa M; Fukutani Y; Sasaki K; Isaki K; Hamano T; Hirayama M; Imamura K; Mukai M; Arai N; Cairns NJ
    Clin Neuropathol; 2000; 19(4):192-9. PubMed ID: 10919351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration.
    Kasashima S; Oda Y
    Acta Neuropathol; 2003 Feb; 105(2):117-24. PubMed ID: 12536222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The reappraisal study of the ultrastructure of Alzheimer's neurofibrillary tangles in three cases of progressive supranuclear palsy].
    Amano N; Iwabuchi K; Yokoi S; Yagishita S; Itoh Y; Saitoh A; Nagatomo H; Matsushita M
    No To Shinkei; 1989 Jan; 41(1):35-44. PubMed ID: 2655673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
    Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
    Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy.
    Kertesz A; McMonagle P
    J Neurol Sci; 2010 Feb; 289(1-2):138-43. PubMed ID: 19733862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.